Phio Pharmaceuticals Corp.
PHIO
Revenue
0.00
0.000.00%
3 Months ChangeAssets
5.30M
▼-1.56M▼-22.72%
3 Months ChangeLiabilities
1.63M
▼-692.00k▼-29.75%
3 Months ChangeFree Cash Flow
-2.71M
▲865.00k▲24.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 8-K
ID: 0001683168-24-005707
2024-08-14
Form 10-Q
ID: 0001683168-24-005706
2024-08-01
Form 8-K
ID: 0001683168-24-005194
2024-07-24
Form 8-K
ID: 0001683168-24-005049
2024-07-12
Form 8-K
ID: 0001683168-24-004800
2024-07-05
Form 8-K
ID: 0001683168-24-004683
2024-07-02
Form 8-K
ID: 0001683168-24-004619
2024-06-21
Form 8-K
ID: 0001683168-24-004417
2024-05-28
Form 8-K
ID: 0001683168-24-003849
2024-05-17
Form 8-K
ID: 0001683168-24-003598